Viatris Inc. announced that it has closed its acquisitions of Oyster Point Pharma and Famy Life Sciences to establish a new Viatris Eye Care Division. The transaction was first announced on November 7 as part of Viatris’ strategic update. Former Oyster Point Pharma CEO, Jeffrey Nau, Ph.D., MMS, will lead the new division.
Tag Archive for: acquisition
Private equity major Advent International will buy a 50.1% stake in Suven Pharmaceuticals Ltd. from its promoter Jasti family and consider merging it with a peer in its portfolio, the Indian drugmaker said on Monday.
Bushu Pharma, established in 1998, is one of the leading manufacturers of pharmaceutical and medical devices in Japan.
Bloomberg reported on Thursday that Medtronic was also open to a sale at the right price and the businesses could be valued at more than $7 billion. The two businesses were also drawing interest from private-equity firms, according to the report.
The company said it would acquire Nimbus Therapeutics’ drug being developed to treat autoimmune conditions such as psoriasis in up to $6 billion deal.
The deal strengthens the agency’s consumer expertise within healthcare and pharma.
Evolution Road will become part of Inizio’s MarComms business unit, Evoke, enhancing its commercial innovation offering, digital health solutions, and end-to-end omnichannel suite of services.
While acquiring Horizon would add a mixed portfolio of specialty drugs to Sanofi’s roster, it would not address the French company’s need to develop its drug pipeline and improve its productivity from research and development, analysts say.
The Ireland-based company issued a statement confirming that it is engaged in “highly preliminary discussions” with Amgen, Janssen, and Sanofi. Any acquisition of Horizon Therapeutics would be among the biggest deals of 2022.
AstraZeneca and Neogene have entered into a definitive acquisition agreement in which AstraZeneca will buy all outstanding equity in the smaller company for $320 million.